Active substance
Retinol
- SFDA 1
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| UNIVIT-A FORT 50000 I.U. CAPSULE | 50000 IU | Capsule · Oral use | 20 Blister | SAR 5.85 | Generic · Prescription | UNITED PHARMACEUTICAL CO. | Valid |
Indications — CHI Daman Drug Formulary
MATERNAL AND CHILD HEALTHCARE- SUPPLEMENTATION FOR MOTHER AND CHILD
WHO WHO Model List of Essential Medicines (2025)
- 27. Vitamins and minerals · core
Vitamin A deficiency
Parenteral > General injections > IM: 50000 IU per mL in 2 mL ampoule or vial water-miscible (as palmitate) | Oral > Liquid: 100000 IU per mL (as palmitate or acetate) | Oral > Solid > capsule: 200000 IU (as palmitate or acetate) soft capsule; 50000 IU (as palmitate) (EML); 100000 IU (as palmitate or acetate) soft capsule
Combinations containing Retinol
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.